Successful control of heavily pretreated metastatic gastric cancer with the mTOR inhibitor everolimus (RAD001) in a patient with PIK3CA mutation and pS6 overexpression

Park, Ji Hyun; Ryu, Min-Hee; Park, Young Soo; Park, Sook Ryun; Na, Young-Soon; Rhoo, Baek-Yeol; Kang, Yoon-Koo

doi:10.1186/s12885-015-1139-7

BMC Cancer

Article metrics
Last updated: Sat, 20 Apr 2024 15:53:03 Z

Successful control of heavily pretreated metastatic gastric cancer with the mTOR inhibitor everolimus (RAD001) in a patient with PIK3CA mutation and pS6 overexpression

Access & Citations

2486

Article Accesses
22

Web of Science
20

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com